Toward Personalized Withdrawal of TNF-α Inhibitors in Non-Systemic Juvenile Idiopathic Arthritis: Predictors of Biologic-Free Remission and Flare.

Pharmaceuticals (Basel) · 2026 · PMC12845067 · PMID 41599723

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Flare rates by withdrawal strategy were 72.0% (18/25) after abrupt discontinuation, 72.0% (18/25) after interval extension, and 84.6% (22/26) after dose reduction; these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.